Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

NCT07361484 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Non-squamous Non-Small Cell Lung Cance

Interventions

DRUG: Plinabulin
DRUG: Docetaxel
DRUG: Placebo (matching plinabulin placebo)

Sponsor

BeyondSpring Pharmaceuticals Inc.